miRecule, Inc.
PrivateLast Round
Series A
Jul 14, 2024
Total Funding Raised
$38.56M
Company Overview
miRecule, Inc. is a biotechnology company developing RNA-based therapies for cancer and muscular dystrophy using its proprietary DREAmiR platform to create highly tailored therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
miRecule, Inc. Comparables
Compare miRecule, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avidity Biosciences | 80% | |
| Epicrispr Biotechnologies | 79% | |
| Novartis | 79% | |
miRecule, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 14, 2024 | ||||
| Strategic | Oct 4, 2022 | ||||
| Grant | Sep 29, 2022 | ||||
| Grant | Feb 28, 2022 | ||||
| Grant | May 27, 2021 | ||||
Seed | May 27, 2021 |
Key People
Founding team and executive leadership
miRecule, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Boutique Venture Partners | Seed |
| Solve FSHD | Grant |
| Alexandria Venture Investments | Seed |
| Pathway Bioventures | Seed |
| FSHD Society | Seed |
| University System of Maryland Momentum Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2024
Completed a Series A funding round.
- Aug 10, 2020
$1.76M grant received from the National Cancer Institute.
miRecule, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about miRecule, Inc.'s valuation, stock price, and market status.